Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|May 25, 2012
Fusion between tumor cells enhances melanoma metastatic potentialRuifang Mi, Chunxiao Pan, Xiaocui Bian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2018
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell PlatformJulian Rydzek, Thomas Nerreter, Haiyong Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2018
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1Junpeng Qi, Xiuling Li, Haiyong Peng, et al.
Frontiers in Oncology|March 21, 2022
A Clinical Assessment of a Magnetic Resonance Computer-Aided Diagnosis System in the Detection of Pathological Complete Response After Neoadjuvant Chemotherapy in Breast CancerHaiyong Peng, Shaolei Yan, Xiaodan Chen, et al.
Frontiers in Oncology|July 12, 2021
Computer-Aided Diagnosis Evaluation of the Correlation Between Magnetic Resonance Imaging With Molecular Subtypes in Breast CancerWei Meng, Yunfeng Sun, Haibin Qian, et al.
Future Oncology (London, England)|June 28, 2023
Prediction model based on radiomics and clinical features for preoperative lymphovascular invasion in gastric cancer patientsPing Wang, Kaige Chen, Ying Han, et al.
Future Oncology (London, England)|December 13, 2021
Computer-aided classification of MRI for pathological complete response to neoadjuvant chemotherapy in breast cancerShaolei Yan, Haiyong Peng, Qiujie Yu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
In vivo affinity maturation of murine B cells reprogrammed to express human antibodiesYiming Yin, Yan Guo, Yuxuan Jiang, et al.
Nature Biomedical Engineering|March 15, 2024
In vivo affinity maturation of mouse B cells reprogrammed to express human antibodiesYiming Yin, Yan Guo, Yuxuan Jiang, et al.
Cancer Immunology Research|July 8, 2018
Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation AntibodiesJing Chang, Haiyong Peng, Brian C Shaffer, et al.
Pageof 5